Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Baricitinib was effective in treating alopecia areata in two major trials.

A man's gray hair got darker and thicker after using a psoriasis drug.

Tislelizumab can cause cutaneous lupus erythematosus.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

The combination therapy was effective and well-tolerated, especially in young patients.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Bimatoprost increases hair growth in mice without breaking down into other substances.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Human insulin via microinfusion may effectively improve atrophic acne scars.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.